problems with ADD medications.

The AD/HD Philosophic Reception: The medical discussion about aspects of my new book has been, quite interestingly, uniformly positive. The theme in my medical presentations is simple, and often addressed here at CorePsychBlog - we often do not use precise parameters with our AD/HD treatment targets, - current diagnostic criteria are imprecise, superficial, amorphous and "move about" too much- does that cover it? If we don't see it how can we hit it? - we don't appreciate the specific trajectories of the drugs we use, and thereby often miss the mark just because we don't adjust our sights correctly, but, rather, too often blast away. Are we shooting howitzers at wrens?